- Home
- TWLO vs SRPT Comparison
TWLO vs SRPT Comparison
Compare TWLO & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TWLO
- SRPT
- Stock Information
- Founded
- TWLO 2008
- SRPT 1980
- Country
- TWLO United States
- SRPT United States
- Employees
- TWLO N/A
- SRPT N/A
- Industry
- TWLO Computer Software: Prepackaged Software
- SRPT Biotechnology: Pharmaceutical Preparations
- Sector
- TWLO Technology
- SRPT Health Care
- Exchange
- TWLO Nasdaq
- SRPT Nasdaq
- Market Cap
- TWLO 11.4B
- SRPT 12.2B
- IPO Year
- TWLO 2016
- SRPT 1997
- Fundamental
- Price
- TWLO $96.56
- SRPT $104.54
- Analyst Decision
- TWLO Buy
- SRPT Strong Buy
- Analyst Count
- TWLO 23
- SRPT 21
- Target Price
- TWLO $83.70
- SRPT $182.00
- AVG Volume (30 Days)
- TWLO 3.4M
- SRPT 1.0M
- Earning Date
- TWLO 10-30-2024
- SRPT 11-06-2024
- Dividend Yield
- TWLO N/A
- SRPT N/A
- EPS Growth
- TWLO N/A
- SRPT N/A
- EPS
- TWLO N/A
- SRPT 1.22
- Revenue
- TWLO $4,339,151,000.00
- SRPT $1,640,348,000.00
- Revenue This Year
- TWLO $8.48
- SRPT $45.98
- Revenue Next Year
- TWLO $7.61
- SRPT $78.13
- P/E Ratio
- TWLO N/A
- SRPT $85.70
- Revenue Growth
- TWLO 5.77
- SRPT 48.45
- 52 Week Low
- TWLO $52.51
- SRPT $78.67
- 52 Week High
- TWLO $101.00
- SRPT $173.25
- Technical
- Relative Strength Index (RSI)
- TWLO 80.80
- SRPT 23.65
- Support Level
- TWLO $70.03
- SRPT $116.32
- Resistance Level
- TWLO $101.00
- SRPT $122.63
- Average True Range (ATR)
- TWLO 3.12
- SRPT 4.97
- MACD
- TWLO 1.17
- SRPT -2.19
- Stochastic Oscillator
- TWLO 85.66
- SRPT 6.47
About TWLO Twilio Inc.
Twilio is a cloud-based communications platform-as-a-service company offering communication building blocks that allow for a fully customized customer engagement experience spanning voice, video, chat, and SMS messaging. It does this through various application programming interfaces and prebuilt solution applications aimed at improving customer engagement. The company leverages its Super Network, a global network of carrier relationships, to facilitate high-speed, cost-effective communication.
About SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's strategy involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Most of company's product candidates are at an early stage of development.